Abstract
1 Nine healthy volunteers received single 1 mg intravenous doses of digitoxin, following which serum digitoxin concentrations were measured at multiple points in time over the next 14 days. 2 Mean kinetic variables for digitoxin were: volume of distribution, 0.76 l/kg; elimination half-life, 8 days; total clearance, 0.049 ml min-1 kg-1. 3 After a drug-free interval of at least 4 months, subjects took 0.07 mg of oral digitoxin daily for 28 consecutive days. Serum digitoxin concentrations were measured during the period of dosage and in the 21 day post-dosage washout. 4 Digitoxin accumulation was slow, proceeding with a mean half-life (7.9 days) that was nearly identical to the single-dose half-life. However, the two were not significantly correlated. 5 Mean observed steady-state serum concentrations (15.4 ng/ml) also were nearly identical to those predicted from the single-dose study (15.3 ng/ml), but again the two were not significantly correlated. 6 Steady state is very slowly attained after initiation of maintenance therapy with digitoxin. The kinetic data suggest that a loading dose on the average should be 12 times the maintenance dose.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Greenblatt D. J., Kock-Weser J. Drug therapy. Clinical Pharmacokinetics (first of two parts). N Engl J Med. 1975 Oct 2;293(14):702–705. doi: 10.1056/NEJM197510022931406. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J. Predicting steady state serum concentrations of drugs. Annu Rev Pharmacol Toxicol. 1979;19:347–356. doi: 10.1146/annurev.pa.19.040179.002023. [DOI] [PubMed] [Google Scholar]
- Haustein K. O. Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment. Eur J Clin Pharmacol. 1981 Jan;19(1):45–51. doi: 10.1007/BF00558383. [DOI] [PubMed] [Google Scholar]
- Ochs H. R., Greenblatt D. J., Bodem G. Single- and multiple-dose kinetics of intravenous digoxin. Clin Pharmacol Ther. 1980 Sep;28(3):340–345. doi: 10.1038/clpt.1980.171. [DOI] [PubMed] [Google Scholar]
- Ochs H. R., Pabst J., Greenblatt D. J., Dengler H. J. Noninteraction of digitoxin and quinidine. N Engl J Med. 1980 Sep 18;303(12):672–674. doi: 10.1056/NEJM198009183031205. [DOI] [PubMed] [Google Scholar]
- Perrier D., Mayersohn M., Marcus F. I. Clinical pharmacokinetics of digitoxin. Clin Pharmacokinet. 1977 Jul-Aug;2(4):292–311. doi: 10.2165/00003088-197702040-00005. [DOI] [PubMed] [Google Scholar]
- Smith T. W. Radioimmunoassay for serum digitoxin concentration: methodology and clinical experience. J Pharmacol Exp Ther. 1970 Nov;175(2):352–360. [PubMed] [Google Scholar]